GetPortalImpactFactorByIdResp(projectId=1, id=95404991, cover=https://img.medsci.cn/images/journal/cover/2021/QIQ_202109271316130450.jpg, fullname=NUCLEAR MEDICINE AND BIOLOGY, abbr=NUCL MED BIOL, pyear=1993, frequence=Bimonthly, articleNumbers=1198, citedSelf2015=8.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0969-8051, greenSci=https://www.greensci.net/search?kw=0969-8051, scijournal=https://www.scijournal.org/impact-factor-of-NUCL-MED-BIOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.973, medsciHotlight=2.112, medsciHotlight5year=2.71611, citescore=4.5, hIndex=88, impactFactor=3.1, orgnization=Elsevier Inc., orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 4 区, website=https://www.journals.elsevier.com/nuclear-medicine-and-biology/, websiteHits=4908, guideForAuthor=null, guideForAuthorHits=9, submitWebsite=https://www.editorialmanager.com/nucmedbio/default.aspx, submitWebsiteHits=1563, content=Nuclear Medicine and Biology is intended for original research contributions describing original synthesis, in vitro tissue studies, or in vivo use of radiotracers, radiopharmaceuticals, or therapeutic agents. Papers concentrate on the synthesis, testing in vitro, and examination of a compound in vivo. Extensive studies proving the mechanism of localization in vivo whether the radioactive substance is based on receptor-, enzyme-, or tumor antigen-binding or other well defined processes are an integral part of each evaluation. Additionally, studies should define a significant compound that is a sensitive probe of a biochemical change in vivo., totalCites=3714, brief=NUCL MED BIOL杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=核医学" >核医学</a></strong>”子行业的中等级别杂志, articleType=该刊全部是论著，可能不接收综述类等文章, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=95404991'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.39), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.12), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.23), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.5)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.539), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.331), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.781), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.007), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.973)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Radiology, Nuclear Medicine and Imaging , rank=70/272), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=98/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=122/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0969-8051[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=NUCLEAR MEDICINE AND BIOLOGY[ta], article_number=586, article_number_cn=3, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)